ATE324873T1 - Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol - Google Patents

Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol

Info

Publication number: ATE324873T1
Authority: AT; Austria
Prior art keywords: derivative; capsule; omeprazole; hpmc; cellulose
Prior art date: 2000-11-20

Application number

AT01983069T

Other languages

English (en)

Inventor

Judita Sirca

Original Assignee

Lek Farmacevtska Druzba Dd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-20

Filing date

2001-11-20

Publication date

2006-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE324873(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-11-20 Application filed by Lek Farmacevtska Druzba Dd filed Critical Lek Farmacevtska Druzba Dd

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE324873T1 publication Critical patent/ATE324873T1/de

Links

239000002775 capsule Substances 0.000 title abstract 3
239000001913 cellulose Substances 0.000 title abstract 3
229920002678 cellulose Polymers 0.000 title abstract 3
SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title 1
150000001556 benzimidazoles Chemical class 0.000 title 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title 1
229960000381 omeprazole Drugs 0.000 title 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
-1 hydroxypropoxy Chemical group 0.000 abstract 1
239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT01983069T 2000-11-20 2001-11-20 Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol ATE324873T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SI200000282A SI20720A (sl)	2000-11-20	2000-11-20	Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola

Publications (1)

Publication Number	Publication Date
ATE324873T1 true ATE324873T1 (de)	2006-06-15

Family

ID=20432767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01983069T ATE324873T1 (de)	2000-11-20	2001-11-20	Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol

Country Status (9)

Country	Link
US (2)	US20040029924A1 (de)
EP (1)	EP1335709B1 (de)
AT (1)	ATE324873T1 (de)
AU (2)	AU1452402A (de)
DE (1)	DE60119367T2 (de)
ES (1)	ES2263675T3 (de)
PL (1)	PL360972A1 (de)
SI (1)	SI20720A (de)
WO (1)	WO2002039980A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY148805A (en) *	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
CL2004000983A1 (es) *	2003-05-08	2005-03-04	Altana Pharma Ag	Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) *	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CA2540105A1 (en) *	2003-09-25	2005-03-31	Natco Pharma Limited	Enteric soft gelatin capsule containing esomeprazole and method of preparation
WO2005034924A1 (en) *	2003-10-14	2005-04-21	Natco Pharma Limited	Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
EP1721604A4 (de) *	2004-03-04	2008-04-30	Takeda Pharmaceutical	Stabiles kapselpräparat
US8461187B2 (en)	2004-06-16	2013-06-11	Takeda Pharmaceuticals U.S.A., Inc.	Multiple PPI dosage form
WO2008018825A1 (en) *	2006-08-10	2008-02-14	Astrazeneca Ab	Oral polyvinyl alcohol capsules comprising proton pump inhibitors
CN116251075B (zh) *	2023-03-31	2024-11-29	江苏慧聚药业股份有限公司	一种兰索拉唑肠溶胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
US5264223A (en) *	1990-03-29	1993-11-23	Japan Elanco Company, Ltd.	Hard capsule for pharmaceutical drugs and method for producing the same
US5431917A (en) *	1992-10-08	1995-07-11	Japan Elanco Company, Ltd.	Hard capsule for pharmaceutical drugs and method for producing the same
US5756123A (en) *	1994-12-01	1998-05-26	Japan Elanco Co., Ltd.	Capsule shell
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms
SI9700186B (sl) *	1997-07-14	2006-10-31	Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.	Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
ZA9810765B (en) *	1998-05-28	1999-08-06	Ranbaxy Lab Ltd	Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
EP1072258A1 (de) *	1999-07-28	2001-01-31	Greither, Peter	Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung

2000
- 2000-11-20 SI SI200000282A patent/SI20720A/sl not_active IP Right Cessation
2001
- 2001-11-20 AU AU1452402A patent/AU1452402A/xx active Pending
- 2001-11-20 EP EP01983069A patent/EP1335709B1/de not_active Revoked
- 2001-11-20 US US10/416,354 patent/US20040029924A1/en not_active Abandoned
- 2001-11-20 AU AU2002214524A patent/AU2002214524B2/en not_active Ceased
- 2001-11-20 DE DE60119367T patent/DE60119367T2/de not_active Revoked
- 2001-11-20 PL PL36097201A patent/PL360972A1/xx not_active Application Discontinuation
- 2001-11-20 ES ES01983069T patent/ES2263675T3/es not_active Expired - Lifetime
- 2001-11-20 AT AT01983069T patent/ATE324873T1/de active
- 2001-11-20 WO PCT/SI2001/000031 patent/WO2002039980A2/en not_active Ceased
2009
- 2009-05-26 US US12/471,910 patent/US20090226511A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20040029924A1 (en)	2004-02-12
US20090226511A1 (en)	2009-09-10
ES2263675T3 (es)	2006-12-16
AU2002214524B2 (en)	2007-03-01
WO2002039980A2 (en)	2002-05-23
PL360972A1 (en)	2004-09-20
AU1452402A (en)	2002-05-27
SI20720A (sl)	2002-06-30
DE60119367T2 (de)	2007-04-19
EP1335709B1 (de)	2006-05-03
EP1335709A2 (de)	2003-08-20
DE60119367D1 (de)	2006-06-08
WO2002039980A3 (en)	2002-07-11

Similar Documents

Publication	Publication Date	Title
NO20023313D0 (no)	2002-07-09	Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme
AR016827A1 (es)	2001-08-01	PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
CL2009001682A1 (es)	2010-07-23	Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
AP1954A (en)	2009-02-10	Controlled release compositions comprising nimesulide.
HUT77886A (hu)	1998-09-28	Ondansetront tartalmazó, fagyasztva szárított készítmények
NO20043723L (no)	2004-09-06	Farmasoytisk doseringform for avgivese gjennom slimhinner
AR027034A1 (es)	2003-03-12	Composicion para dosis oral de liberacion extendida
NO20011721D0 (no)	2001-04-05	N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
IL143375A0 (en)	2002-04-21	Sustained release matrix systems for highly soluble drugs
ATE324873T1 (de)	2006-06-15	Zellulosederivatkapsel, wie z. b. hpmc, die benzimidazolderivat enthaelt, wie z.b. omeprazol
ATE292453T1 (de)	2005-04-15	Antivirale arznei
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
LV10268A (lv)	1994-10-20	Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
MXPA04003346A (es)	2004-09-28	Formulacion de dosis oral de disolucion instantanea.
NO20013205D0 (no)	2001-06-26	Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler
NO178336C (no)	1996-03-06	Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
YU47044B (sh)	1994-12-28	Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
ES2194618T1 (es)	2003-12-01	Composicion oralmente desintegrable que comprende mirtazapina.
ATE266404T1 (de)	2004-05-15	Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
CO5170463A1 (es)	2002-06-27	Formas polimorfas de un citrato de azobiciclo [2,2,2]octan- 3-amina y sus composiciones farmaceuticas
AR018041A1 (es)	2001-10-31	Formulaciones de tiagabina de liberacion prolongada, encapsulada y en comprimidos
FR2797446B1 (fr)	2001-11-02	Derives de phenanthroline-7-ones et leurs applications en therapeutique
YU28404A (sh)	2006-08-17	Brzo topljiva formulacija za oralno doziranje
MY145885A (en)	2012-05-15	Controlled release formulations for oral administration
ECSP003607A (es)	2000-09-22	Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1335709

Country of ref document: EP